These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1335391)

  • 1. Angiotensin II regulates the metabolism but not the secretion of vasoactive intestinal peptide in the rabbit.
    Davis RE; Macdonald GJ; Duggan KA
    Clin Sci (Lond); 1992 Nov; 83(5):557-60. PubMed ID: 1335391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral sodium regulates extrahepatic metabolism of vasoactive intestinal peptide.
    Hawley CM; Duggan KA; Macdonald GJ; Shelley S
    Clin Sci (Lond); 1991 Jul; 81(1):79-83. PubMed ID: 1649728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute but not chronic gastric sodium administration regulates vasoactive intestinal peptide metabolism by the liver.
    Hawley CM; Duggan KA; MacDonald GJ; Shelley S
    Acta Physiol Scand; 1991 Nov; 143(3):295-8. PubMed ID: 1772038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide regulates angiotensin II catabolism in the rabbit.
    Davis RE; Ye VZ; Macdonald GJ; Duggan KA
    Acta Physiol Scand; 1995 Mar; 153(3):255-61. PubMed ID: 7625178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a high sodium diet on the metabolism and secretion of vasoactive intestinal peptide in the rabbit.
    Davis RE; Shelley S; MacDonald GJ; Duggan KA
    J Physiol; 1992; 451():17-23. PubMed ID: 1403810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium depletion decreases hepatic metabolism of vasoactive intestinal peptide in the rabbit.
    Duggan KA; Hawley CM; Macdonald GJ; Shelley S
    J Physiol; 1989 Nov; 418():251-9. PubMed ID: 2621618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of vasoactive intestinal peptide release and metabolism by sodium.
    Duggan KA; Shelley S; Macdonald GJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S21-3. PubMed ID: 1708016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of endopeptidase 24.11 inhibition on plasma and tissue concentrations of vasoactive intestinal peptide.
    Duggan KA; Jones DM; Ye VZ; Davis RE; Macdonald GJ
    Clin Sci (Lond); 1995 Sep; 89(3):267-71. PubMed ID: 7493422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide down-regulates the intrahepatic renin-angiotensin system in the anaesthetized rat.
    Ye VZ; Duggan KA
    Clin Sci (Lond); 2000 Sep; 99(3):201-6. PubMed ID: 11787472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II: a humoral mediator for the gastric sodium monitor.
    Duggan KA; Ye VZ; Jones DM; Macdonald GJ
    Am J Physiol; 1996 Mar; 270(3 Pt 2):F406-10. PubMed ID: 8780241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the decrease in circulating angiotensin II concentration after sodium loading.
    Duggan KA; Ye VZ
    Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):818-9. PubMed ID: 9784922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial vasoactive intestinal peptide and fibrosis induced by nitric oxide synthase inhibition in the rat.
    Ye VZ; Hodge G; Yong JL; Duggan KA
    Acta Physiol Scand; 2003 Dec; 179(4):353-60. PubMed ID: 14656372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sodium depletion on tissue concentrations of the natriuretic hormone vasoactive intestinal peptide.
    Duggan KA; Ye VZ
    Clin Exp Pharmacol Physiol; 1995 Aug; 22(8):583-4. PubMed ID: 7586717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model.
    Hu DE; Hiley CR; Fan TP
    Br J Pharmacol; 1996 Feb; 117(3):545-551. PubMed ID: 8821547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels.
    Duggan KA; Ye VZ
    Eur J Pharmacol; 1998 Sep; 358(1):25-30. PubMed ID: 9809865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of vasoactive intestinal peptide on the rat adrenal zona glomerulosa.
    Hinson JP; Puddefoot JR; Kapas S
    J Endocrinol; 1999 Apr; 161(1):51-7. PubMed ID: 10194528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dietary sodium on the concentrations of vasoactive intestinal peptide in plasma and lung.
    Ye VZ; Duggan KA
    Chest; 1995 Aug; 108(2):535-8. PubMed ID: 7634895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay study of hepatic clearance and disappearance half-time of somatostatin and vasoactive intestinal peptide in dogs.
    Chayvialle JA; Rayford PL; Thompson JC
    Gut; 1981 Sep; 22(9):732-7. PubMed ID: 6117506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidipsogenic action of vasoactive intestinal peptide in the rat.
    Itoh S; Yoshikawa K
    Neuropharmacology; 1985 Aug; 24(8):793-5. PubMed ID: 3837859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.